IDEXX Laboratories, Inc.IDXXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.84% | +3.56% | +10.55% | +13.29% | +14.28% |
| Gross Profit Growth | +8.46% | +5.11% | +11.89% | +14.65% | +15.33% |
| EBITDA Growth | +7.14% | +5.16% | +36.15% | +14.64% | +19.31% |
| Operating Income Growth | +6.68% | +5.88% | +41.41% | +16.77% | +20.60% |
| Net Income Growth | +11.12% | +3.01% | +44.61% | +17.94% | +14.82% |
| EPS Growth | +12.39% | +4.93% | +48.78% | +21.20% | +17.87% |
| EPS Diluted Growth | +12.93% | +5.34% | +48.77% | +21.43% | +17.56% |
| Weighted Average Shares Growth | -1.49% | -2.14% | -2.68% | -2.68% | -2.14% |
| Weighted Average Shares Diluted Growth | -1.66% | -2.42% | -2.88% | -2.87% | -2.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +4.87% | +19.83% | -25.20% | +82.82% | +34.35% |
| Free Cash Flow Growth | +2.52% | +23.54% | -29.47% | +93.36% | +44.81% |
| Receivables Growth | +6.00% | +4.48% | +9.07% | +21.79% | +23.49% |
| Inventory Growth | +0.42% | +1.38% | +3.32% | +0.45% | -1.08% |
| Asset Growth | +1.03% | -4.17% | -2.46% | +1.07% | +1.74% |
| Book Value per Share Growth | +9.09% | -5.69% | -5.14% | -0.85% | +2.83% |
| Debt Growth | -7.53% | -0.90% | +15.86% | +11.49% | +9.15% |
| R&D Expense Growth | +11.42% | +12.21% | +11.63% | +17.48% | +15.77% |
| SG&A Expenses Growth | +9.69% | +2.61% | -13.38% | +11.31% | +9.72% |